Recent examples of applications of molecular neuroimaging in transgenic animals
Type of Genetically Engineered Model | Promoter Expression | Location of Model | Animal Method | Imaging | Application | Reference |
---|---|---|---|---|---|---|
Transgenic | Estrogen receptor | Ubiquitous + brain | Mice | Fluc BLI | Study of estrogen control of growth, differentiation, and function of many systems; study of implications for estrogen-replacement therapy | 44 |
Transgenic | GFAP | Brain | Mice | Fluc BLI | Dynamic monitoring of neuronal cell death | 45 |
Transgenic | Smad binding element responsive to TGF-β signaling | Brain | Mice | Fluc BLI | Study of Smad2/3 activation in traumatic brain injury | 46 |
Transgenic | Smad binding element responsive to TGF-β signaling | Brain | Mice | Fluc BLI | Study of Smad2activation in neuronal degeneration | 47 |
Transgenic | Serum amyloid A protein 1 | Ubiquitous + brain | Mice | Fluc BLI | Study of role of SAA1 induction in chronic inflammation associated with amyloid deposition | 48 |
Gene targeting knockin | CMV | Ubiquitous + brain | Mice | GFP and RFP fluorescence | Study of alternative splicing regulation of FGFR-2 in the brain. | 49 |
Transgenic | IκBα | Ubiquitous + brain | Mice | Fluc BLI | Study of regulation of IκBαexpression and NF-κB transcriptional activity | 50 |
Transgenic | Mouse GFAP | Brain | Mice | Fluc BLI | Study of meningitis and accompanying neuronal injury | 51 |
Transgenic | c-fos, CMV | Ubiquitous + brain | Mice | Fluc BLI | Study of immediate-early genes involved in neural pathways linked to specific behaviors | 52 |
Transgenic | Estrogen-responsive elements | Ubiquitous + brain | Mice | Fluc BLI | Study of activation of estrogen receptors and kinetics of gene activation by estrogenic compounds | 53 |
Conditional recombinase knockout | Pro-opiomelanocortin | Pituitary | Mice | Fluc BLI | Study of spontaneous retinoblastoma pathway-dependent pituitary cancer and its response to doxorubicin | 54 |
Transgenic | E2F1 | Brain | Mice | Fluc BLI | Imaging cell proliferation in gliomas with loss of RB control | 55 |
Note:—BLI indicates bioluminescence imaging; FGFR-2, fibroblast growth factor receptor-2; CMV, cytomegalovirus; GFP, green fluorescent protein; RFP, red fluorescent protein; IκBα, an inhibitor of nuclear transcription factor NF-κB, which regulates the expression of proinflammatory and cytotoxic genes; c-fos, an immediate early gene; RB, retinoblastoma protein.